Skip to main content
. 2015 May 20;10(5):e0126727. doi: 10.1371/journal.pone.0126727

Table 3. Relevant HLA allele and block associations in SSc patients compared to healthy controls.

HLA Block or allele SSc (N = 316) lcSSc (N = 188) dcSSc (N = 128) Controls (N = 468) Comparissons, (pC value, Odds Ratio, 95% CI) Association
n (g.f.) n (g.f.) n (g.f.) n (g.f.)
C*07:02 43 (0.1360) 33 (0.1750) 10 (0.0780) 97 (0.2070) SSc vs Ctls (Yates pC = 0.01, OR = 0.60, 95%CI = 0.40–0.89), dcSSc vs Ctls (Yates pC = 0.001, OR = 0.32, 95%CI = 0.16–0.64), lcSSc vs Ctls (pC = ns), dcSSc vs lcSSc (Yates pC = 0.02, OR = 0.39, 95%CI = 0.18–0.84) Protection to dcSSc
B*39:06 18 (0.0560) 15 (0.0790) 3 (0.0230) 32 (0.0680) SSc vs Ctls (pC = ns), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (pC = ns)
B*39:05 13 (0.0410) 10 (0.0530) 3 (0.0230) 37 (0.0790) SSc vs Ctls (pC = ns), dcSSc vs Ctls (Yates pC = 0.04, OR = 0.27, 95%CI = 0.08–0.92), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (pC = ns)
C*07:02-B*39:06 18 (0.0569) 15 (0.0798) 3 (0.0234) 29 (0.0619) SSc vs Ctls (pC = ns), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (pC = ns)
C*07:02-B*39:05 12 (0.0379) 10 (0.0532) 2 (0.0156) 34 (0.0726) SSc vs Ctls (pC = ns), dcSSc vs Ctls (Yates pC = 0.02, OR = 0.20, 95%CI = 0.04–0.85), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (pC = ns)
C*07:02-B*39:06 + C*07:02-B*39:05 30 (0.0949) 25 (0.1329) 5 (0.0390) 63 (0.1346) SSc vs Ctls (pC = ns), dcSSc vs Ctls (Yates pC = 0.004, OR = 0.26, 95%CI = 0.10–0.66), lcSSc vs Ctls (pC = ns), dcSSc vs lcSSc (Yates pC = 0.009, OR = 0.26, 95%CI = 0.09–0.71) Protection to dcSSc
HLA Block or allele
C*07:01 23 (0.0720) 11 (0.0580) 12 (0.0930) 25 (0.0530) SSc vs Ctls (pC = ns), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (pC = ns), dcSSc vs lcSSc (pC = ns)
B*08:01 14 (0.0440) 8 (0.0420) 6 (0.0460) 3 (0.0060) SSc vs Ctls (Yates pC = 0.0008, OR = 7.1, 95%CI = 2.04–25.21), dcSSc vs Ctls (Yates pC = 0.003, OR = 7.6, 95%CI = 1.88–30.92), lcSSc vs Ctls (Yates pC = 0.003, OR = 6.8; 95%CI = 1.8–26.25), dcSSc vs lcSSc (pC = ns) Susceptibility to SSc
C*07:01-B*08:01 11 (0.0348) 6 (0.0319) 5 (0.0391) 3 (0.0064) SSc vs Ctls (Yates pC = 0.007, OR = 5.59, 95%CI = 1.54–20.20), dcSSc vs Ctls (Yates pC = 0.01, OR, 6.3, 95%CI = 1.48–26.73), lcSSc vs Ctls (Yates pC = 0.03, OR = 5.1, 95%CI = 1.26–20.65), dcSSc vs lcSSc (pC = ns) Susceptibility to SSc
HLA Block or allele
C*12:03 18 (0.0560) 7 (0.0370) 9 (0.0700) 12 (0.0250) SSc vs Ctls (Yates pC = 0.04, OR = 2.29, 95% CI = 1.09–4.83), dcSSc vs Ctls (Yates pC = 0.03, OR = 2.87, 95%CI = 1.18–6.98), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (pC = ns)
B*18:01 12 (0.0370) 5 (0.0260) 7 (0.0540) 8 (0.0170) SSc vs Ctls (pC = ns), dcSSc vs Ctls (Yates pC = 0.03, OR = 3.32, 95%CI = 1.18–9.35), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (pC = ns)
C*12:03-B*18:01 7 (0.0198) 1 (0.0053) 6 (0.0469) 2 (0.0042) SSc vs Ctls (Yates pC = 0.04, OR = 5.27, 95%CI = 1.08–25.57), dcSSc vs Ctls (Yates pC = 0.001, OR = 11.46, 95%CI = 2.28–57.48), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (Yates pC = 0.03, OR = 9.1, 95%CI = 1.09–77.32) Susceptibility to dcSSc
HLA Block or allele
DRB1*11:04 13 (0.0410) 3 (0.0150) 10 (0.0780) 8 (0.0170) SSc vs Ctls (pC = ns), dcSSc vs Ctls (Yates pC = 0.001, OR = 4.87, 95%CI = 1.88–12.02), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (Yates pC = 0.01, OR = 5.22, 95%CI = 1.40–19.38) Susceptibility to SSc
DQB1*03:01 46 (0.1450) 24 (0.1270) 22 (0.1710) 116 (0.2470) SSc vs Ctls (Yates pC = 0.0007, OR = 0.51, 95%CI = 0.35–0.75), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (Yates pC = 0.0009, OR = 0.44, 95%CI = 0.27–0.71), dcSSC vs lcSSc (pC = ns) Protection to SSc (lcSSc)
DRB1*11:04-DQB1*03:01 11 (0.0348) 2 (0.0106) 9 (0.0703) 8 (0.0171) SSc vs Ctls (pC = ns), dcSSc vs Ctls (Yates pC = 0.001, OR = 4.87, 95%CI = 1.64–11.51), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (Yates pC = 0.01, OR = 7.03, 95%CI = 1.49–33.10) Susceptibility to SSc
HLA Block or allele
DRB1*01:02 16 (0.0500) 11 (0.0580) 5 (0.0390) 11 (0.0230) SSc vs Ctls (pC = ns), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (pC = 0.04, OR = 2.58, 95%CI = 1.1–6.06), dcSSc vs lcSSc (pC = ns)
DRB1*0101 12 (0.0370) 10 (0.0530) 2 (0.0150) 9 (0.0190) SSc vs Ctls (pC = ns), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (Yates pC = 0.03, OR = 2.8; 95%CI = 1.1–7.1), dcSSC vs lcSSc (pC = ns)
DQB1*05:01 32 ((0.1010) 21 (0.1110) 11 (0.0850) 32 (0.0680) SSc vs Ctls (pC = ns), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (pC = ns), dcSSc vs lcSSc (pC = ns)
DRB1*01:02-DQB1*05:01+DRB1*01:01-DQB1*0501 28 (0.0800) 21 (0.1117) 7 (0.0546) 20 (0.0427) SSc vs Ctls (Yates pC = 0.01, OR = 2.1, 95%CI = 1.20–3.93), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (Yates pC = 0.001, OR = 2.80, 95%CI = 1.48–5.32), dcSSc vs lcSSc (pC = ns) Susceptibiity to SSc
HLA Block or allele
DRB1*04:04 17 (0.053) 15 (0.079) 2 (0.015) 31 (0.066) SSc vs Ctls (pC = ns), dcSSc vs Ctls (Yates pC = 0.04, OR = 0.2, 95%CI = 0.05–0.94), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (Yates pC = 0.02, OR = 0.18, 95%CI = 0.04–0.81)
DQB1*03:02 84 (0.26) 57 (0.303) 27 (0.21) 115 (0.245) SSc vs Ctls (pC = ns), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (pC = ns)
DRB1*04:04/DQB1*03:02 17 (0.053) 15 (0.079) 2 (0.015) 29 (0.062) SSc vs Ctls (pC = ns), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (Yates pC = 0.02, OR = 0.1, 95%CI = 0.01–0.8)
HLA Block or allele
DRB1*14:06 13 (0.0410) 8 (0.0420) 5 (0.0390) 47 (0.1000) SSc vs Ctls (Yates pC = 0.002, OR = 0.30, 95%CI = 0.20–0.72), dcSSc vs Ctls (Yates pC = 0.04, OR = 0.36, 95%CI = 0.14–0.93), lcSSc vs Ctls (Yates pC = 0.02, OR = 0.39, 95%CI = 0.18–0.85), dcSSC vs lcSSc (pC = ns) Protection to SSc
DRB1*16:02 7 (0.0220) 4 (0.0210) 3 (0.0230) 30 (0.0640) SSc vs Ctls (Yates pC = 0.01, OR = 0.33, 95%CI = 0.14–0.70), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (Yates pC = 0.04, OR = 0.31, 95%CI = 0.11–0.91), dcSSC vs lcSSc (pC = ns)
DRB1*14:02 nd nd nd 11 (0.0235) SSc vs Ctls (Yates pC = 0.03, OR = 0.12, 95%CI = 0.01–0.93), dcSSc vs Ctls (pC = 0.3), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (pC = ns)
DQB1*03:01 46 (0.1450) 24 (0.1270) 22 (0.1710) 116 (0.2470) SSc vs Ctls (Yates pC = 0.0007, OR = 0.51, 95%CI = 0.35–0.75), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (Yates pC = 0.0009, OR = 0.44, 95%CI = 0.27–0.71), dcSSC vs lcSSc (pC = ns) Protection to SSc (lcSSc)
DRB1*1406-DQB1*0301 12 (0.0380) 8 (0.0426) 4 (0.0313) 46 (0.0983) SSc vs Ctls (Yates pC = 0.002, OR = 0.36, 95%CI = 0.18–0.69), dcSSc vs Ctls (Yates pC = 0.02, OR = 0.29, 95%CI = 0.10–0.83), lcSSc vs Ctls (Yates pC = 0.02, OR = 0.40, 95%CI = 0.18–0.88), dcSSC vs lcSSc (pC = ns) Protection to SSc
DRB1*16:02-DQB1*0301 7 (0.0222) 4 (0.0213) 3 (0.0234) 30 (0.0641) SSc vs Ctls (Yates pC = 0.01, OR = 0.33, 95%CI = 0.14–0.76), dcSSc vs Ctls (pC = ns), lcSSc vs Ctls (Yates pC = 0.04, OR = 0.3; 95%CI = 0.1–0.9), dcSSC vs lcSSc (pC = ns) Protection to SSc
DRB1*14:02-DQB1*03:01 nd nd nd 11 (0.0235) SSc vs Ctls (Yates pC = 0.03, OR = 0.12, 95%CI = 0.01–0.93), dcSSc vs Ctls (pC = 0.3), lcSSc vs Ctls (pC = ns), dcSSC vs lcSSc (pC = ns) Protection to SSc
DRB1*1406-DQB1*0301 + DRB1*16:02-DQB1*0301 +DRB1*14:02-DQB1*03:01 19 (0.0601) 12 (0.0638) 7 (0.0546) 87 (0.1858) SSc vs Ctls (Yates pC = 0.000001, OR = 0.28, 95%CI = 0.16–0.47), dcSSc vs Ctls (Yates pC = 0.005, OR = 0.25, 95%CI = 0.11–0.56), lcSSc vs Ctls (Yates pC = 0.0001, OR = 0.29, 95%CI = 0.15–0.56), dcSSC vs lcSSc (pC = ns) Protection to SSc

SSc: Systemic sclerosis patients, dcSSc: diffuse cutaneous systemic sclerosis, lcSSc: limited cutaneous systemic sclerosis, pC: p corrected value, OR: odds ratio, 95% CI: 95% confidence interval, ns: non-significant, nd: not detected.